Accueil>>Signaling Pathways>> Cell Cycle/Checkpoint>> Mps1>>Mps1-IN-1 dihydrochloride

Mps1-IN-1 dihydrochloride

Catalog No.GC50110

Le dichlorhydrate de Mps1-IN-1 est un inhibiteur puissant et compétitif de la kinase Mps1 avec une IC50 de 367 nM. Le dichlorhydrate de Mps1-IN-1 inhibe l'activité de la kinase mitotique Mps1 et supprime la fonction du point de contrÔle de l'assemblage du fuseau (SAC). Le dichlorhydrate de Mps1-IN-1 diminue la viabilité des cellules cancéreuses et « normales ».

Products are for research use only. Not for human use. We do not sell to patients.

Mps1-IN-1 dihydrochloride Chemical Structure

Cas No.: 1883548-93-3

Taille Prix Stock Qté
10 mg
506,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 367 nM); exhibits >1000 fold-selectivity against a panel of 352 kinases with the exceptions of ALK and Ltk. Disrupts the recruitment of Mad2 to kinetochores. Increases frequency of multipolar mitosis in U2OS cells.

Kwiatkowski et al (2010) Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function. Nat.Chem.Biol. 6 359 PMID:20383151 |Miduturu et al (2011) High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors. Chem.Biol. 18 868 PMID:21802008 |Lan and Cleveland (2010) A chemical tool box defines mitotic and interphase roles for Mps1 kinase. J.Cell Biol. 190 21 PMID:20624898

Avis

Review for Mps1-IN-1 dihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Mps1-IN-1 dihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.